Investors & Media
The information below is supplied for the purposes of complying with AIM Rule 26 and was last updated on 19 April 2016.
View management team biographies
Shareholders with >3% of total issued:
Pursuant to the AIM Rules, and insofar as the Company is aware, as at 19/04/16, 62.6% of the Company’s AIM securities were not in public hands
Share This Page
Subscribe to Our Newsletter:
Copyright © 2017 Amryt Pharma plc